1. Home
  2. Live Updates
  3. Drug designation

Live Breaking News & Updates on Drug designation

Stay informed with the latest breaking news from Drug designation on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Drug designation and stay connected to the pulse of your community

Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2024

EQS-News: Heidelberg Pharma AG


/ Key word: Quarterly / Interim Statement





Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2024






25.04.2024 /...

Australia , Germany , Melbourne , Victoria , United-states , Frankfurt , Brandenburg , Delaware , Katie-flint , Sylvia-wimmer , Andreas-pahl , Mary-clark

EQS-News: Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2024

EQS-News: Heidelberg Pharma AG: Interim Management Statement on the First Three Months of 2024
finanzen.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.ch Daily Mail and Mail on Sunday newspapers.

Australia , United-states , Frankfurt , Brandenburg , Germany , Melbourne , Victoria , Delaware , Katie-flint , Mary-clark , Sylvia-wimmer , Andreas-pahl

Mereo BioPharma : UK Annual Report 2023 - MarketScreener

Company Number 09481161


MEREO BIOPHARMA GROUP PLC


Annual Report and Accounts


Year ended December 31, 2023

...

London , City-of , United-kingdom , United-states , Bishopsgate , United-kingdom-general- , America , Feng-biosciences , Justin-roberts , Deepa-pakianathan , Marc-yoskowitz , Pierre-jacquet

Cyclo Therapeutics : Corporate Presentation

NASDAQ: CYTH cyclotherapeutics.com






Forward-Looking Statements




2

...

United-states , Johannesburg , Gauteng , South-africa , Australia , Australian , Benny-liu , Geraldf-cox , Sharonh-hrynkow , Michael-lisjak , Karen-mullen , Caroline-hastings

FDA Grants Orphan Drug Designation for CAN-2409 to Treat Pancreatic Cancer

The designation was granted based on overall survival data from an ongoing randomized phase 2 clinical trial.

Sebastian-kaulitzki , Garrett-nichols , National-cancer-institute , National-library-of-medicine , Candel-therapeutics-inc , Orphan-drug-designation , Candel-therapeutics , Chief-medical-officer , End-results , Paul-peter-tak , Chief-executive-officer

Candel Therapeutics Receives FDA Orphan Drug Designation for CAN-2409 for the Treatment of Pancreatic Cancer

Candel Therapeutics Receives FDA Orphan Drug Designation for CAN-2409 for the Treatment of Pancreatic Cancer
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states , Garrett-nichols , Aljanae-reynolds , Theodore-jenkins , National-cancer-institute , Candel-therapeutics-inc , Business-development , Company-nasdaq , Exchange-commission , Drug-administration , Orphan-drug-designation , Paul-peter-tak

FDA Grants Orphan Drug Designation for the Treatment of Scleroderma

/PRNewswire/ -- BLR Bio, an emerging biotechnology company in Rosalind Franklin University's Helix 51 biomedical incubator, announced that the U.S. Food and...

Saskatchewan , Manitoba , Canada , Canadian , Ronald-kaplan , Drug-administration , Canadian-institutes-of-health-research , Rosalind-franklin-university-of-medicine , University-of-saskatchewan , National-scleroderma-foundation , Office-of-marketing , Rosalind-franklin-university

ViGeneron Announces First Patient Dosed in Phase 1b Clinical Trial of VG901 for the Intravitreal Treatment of Retinitis Pigmentosa

VG901 is the first and only clinical-stage therapy designed to deliver a functional CNGA1 gene to retinal photoreceptor target cells in retinitis ...

United-states , Germany , Munich , Bayern , Vigeneron-gmb , Katarina-stingl , Shaun-brown-julia , Mc-services , Orphan-drug-designation , Generon-gmbh , Hereditary-retinal-degenerations , Rare-eye-diseases

Lisata Therapeutics Announces U.S. FDA Orphan Drug Designation Granted to LSTA1 for the Treatment of Osteosarcoma

BASKING RIDGE, N.J., April 09, 2024 -- Lisata Therapeutics, Inc. , a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other...

United-states , John-menditto , Corporate-communications , Exchange-commission , Nasdaq , Company-on , Lisata-therapeutics-inc , Drug-administration , Orphan-drug-designation , Rare-pediatric-disease-designation , Executive-vice-president , Chief-medical-officer

Lisata Therapeutics (LSTA) Announces U.S. FDA Orphan Drug Designation Granted to LSTA1 for the Treatment of Osteosarcoma

Lisata Therapeutics (LSTA) Announces U.S. FDA Orphan Drug Designation Granted to LSTA1 for the Treatment of Osteosarcoma
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states , Company-on , Nasdaq , Drug-administration , Lisata-therapeutics-inc , Lisata-therapeutics , Orphan-drug-designation , Rare-pediatric-disease-designation , Executive-vice-president , Chief-medical-officer , Drug-designation